Description
POLMAWAR-P Tablets contain a combination of Polmacoxib (2 mg) and Paracetamol (325 mg). This unique formulation provides dual-action pain relief by combining a selective COX-2 inhibitor (Polmacoxib) with a safe analgesic-antipyretic (Paracetamol).
Mechanism of Action
Polmacoxib – A highly selective COX-2 inhibitor that reduces inflammation and pain with a lower risk of gastric side effects compared to traditional NSAIDs.
Paracetamol – Works centrally to relieve pain and reduce fever by inhibiting prostaglandin synthesis in the brain.
Indications:
Osteoarthritis:
Polmawar p Used for the management of pain, tenderness, and stiffness associated with degenerative joint disease. Polmawar p provides both anti-inflammatory and analgesic effects, improving joint mobility and functional capacity.
Rheumatoid Arthritis:
Polmawar p is Indicated for symptomatic relief of inflammation, swelling, and pain in patients with rheumatoid arthritis. The COX-2 selective inhibition of Polmacoxib helps reduce joint inflammation, while Paracetamol enhances overall pain control.
Ankylosing Spondylitis:
Polmawar p Provides relief from pain and spinal stiffness associated with chronic inflammatory arthritis of the axial skeleton. Polmawar p helps improve spinal mobility and reduce discomfort in affected individuals.
Acute Musculoskeletal Disorders (e.g., sprains, strains, soft-tissue injuries):
Polmawar p Indicated for short-term treatment of pain and inflammation resulting from acute musculoskeletal injuries. Polmawar p effectively reduces inflammation, swelling, and pain, promoting faster recovery and improved physical function.
